Compare APTV & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APTV | PODD |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 17.0B |
| IPO Year | 2011 | 2007 |
| Metric | APTV | PODD |
|---|---|---|
| Price | $70.96 | $215.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 20 |
| Target Price | $95.40 | ★ $357.65 |
| AVG Volume (30 Days) | ★ 1.9M | 839.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.75 | ★ 3.48 |
| Revenue | ★ $20,398,000,000.00 | $2,708,100,000.00 |
| Revenue This Year | $7.51 | $24.33 |
| Revenue Next Year | $4.82 | $19.33 |
| P/E Ratio | $94.63 | ★ $64.99 |
| Revenue Growth | 3.47 | ★ 30.73 |
| 52 Week Low | $47.19 | $216.49 |
| 52 Week High | $88.93 | $354.88 |
| Indicator | APTV | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 29.20 |
| Support Level | $69.38 | N/A |
| Resistance Level | $72.22 | $299.75 |
| Average True Range (ATR) | 2.01 | 7.61 |
| MACD | 0.21 | -0.52 |
| Stochastic Oscillator | 59.72 | 1.66 |
Aptiv PLC is an industrial technology company focused on enabling a more automated, electrified and digitalized future. The company's technologies reach from sensor to cloud, including the hardware and software necessary to support automotive and other industries on a global basis. Its Advanced Safety and User Experience segment provides advanced software and services, intelligent sensors and high-performance compute platforms; its Engineered Components Group segment provides connection systems, high-performance interconnects, and cable management and protection solutions; and its Electrical Distribution Systems segment provides low voltage and high voltage power, signal and data distribution.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.